These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9205745

  • 1. Involvement of endogenous nitric oxide and sulfhydryl compounds in ebrotidine-induced gastroprotection.
    Palop D, Conejo L, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):468-71. PubMed ID: 9205745
    [Abstract] [Full Text] [Related]

  • 2. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
    Palop D, Romero A, Villamayor F, Conejo L, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
    [Abstract] [Full Text] [Related]

  • 3. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
    Konturek PC, Brzozowski T, Konturek SI, Márquez M, Torres J, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
    [Abstract] [Full Text] [Related]

  • 4. Gastroprotective properties of ebrotidine. A review.
    Slomiany BL, Piotrowski J, Slomiany A.
    Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
    [Abstract] [Full Text] [Related]

  • 5. Study on the increment of the amount of gastric mucus in rats after repeated-dose administration of ebrotidine.
    Romero A, Villamayor F, Palop D, Falcó J, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):455-8. PubMed ID: 9205743
    [Abstract] [Full Text] [Related]

  • 6. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D, Agut J, Márquez M, Conejo L, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [Abstract] [Full Text] [Related]

  • 7. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
    Slomiany BL, Piotrowski J, Slomiany A.
    Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Nitric oxide synthase inhibition negates bombesin-induced gastroprotection.
    Castañeda AA, Kim YS, Chang LK, Cui Y, Mercer DW.
    Surgery; 2000 Sep; 128(3):422-8. PubMed ID: 10965314
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Regulation of gastric mucosal calcium channel activity by an antiulcer agent, ebrotidine.
    Slomiany BL, Liu J, Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A.
    J Physiol Pharmacol; 1994 Mar; 45(1):121-31. PubMed ID: 7519082
    [Abstract] [Full Text] [Related]

  • 15. Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
    Romero A, Gómez F, Villamayor F, Ballesta A, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):524-7. PubMed ID: 9205757
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute toxicity studies of ebrotidine.
    Grau MT, Romero A, Villamayor F, Sacristán A, Ortiz JA.
    Arzneimittelforschung; 1997 Apr; 47(4A):490-1. PubMed ID: 9205750
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.